Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022)

Tilray Brands (TLRY) posted Depreciation & Amortization (CF) of $34.1 million for Q3 2022, down 16.43% on a QoQ basis from $40.8 million in Q2 2022, and down 13.38% year-over-year from $39.3 million in Q3 2021.

Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022) Analysis & Trends

Tilray Brands' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $34.1 million for Q3 2022.

  • Quarterly Depreciation & Amortization (CF) fell 13.38% year-over-year to $34.1 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $34.1 million (down 77.96% YoY) and the FY2022 annual result came in at $154.6 million, up 127.9% from the prior year.
  • Depreciation & Amortization (CF) was $34.1 million for Q3 2022 at Tilray Brands, down from $40.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $40.8 million in Q2 2022 and bottomed at $479000.0 in Q1 2018.
  • A 5-year average of $16.8 million and a median of $11.5 million in 2020 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) jumped 552.55% — and 2022, when it decreased 13.38%.
  • Tilray Brands' Depreciation & Amortization (CF) stood at $2.9 million in 2018, then surged by 190.21% to $8.5 million in 2019, then surged by 40.86% to $12.0 million in 2020, then soared by 211.45% to $37.5 million in 2021, then declined by 9.08% to $34.1 million in 2022.
  • Business Quant data shows TLRY's Depreciation & Amortization (CF) at $34.1 million in Q3 2022, $40.8 million in Q2 2022, and $37.0 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2022 34.07 Mn
Aug 31, 2022 34.07 Mn
May 31, 2022 40.77 Mn
May 31, 2022 40.77 Mn
Feb 28, 2022 37.02 Mn
Feb 28, 2022 37.02 Mn
Nov 30, 2021 37.47 Mn
Nov 30, 2021 37.47 Mn
Aug 31, 2021 39.33 Mn
Aug 31, 2021 39.33 Mn
May 31, 2021 24.54 Mn
May 31, 2021 24.54 Mn
Nov 30, 2020 12.03 Mn
Nov 30, 2020 12.03 Mn
Aug 31, 2020 10.98 Mn
Aug 31, 2020 10.98 Mn
May 31, 2020 25.21 Mn
May 31, 2020 25.21 Mn
Mar 31, 2020 4.56 Mn
Mar 31, 2020 4.56 Mn